Risk factors in autism: Thinking outside the brain
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorders (ASD) are complex neurodevelopmental conditions that have been rising markedly in prevalence for the past 30 years, now thought to affect 1 in 68 in the United States. This has prompted the search for possible explanations, and has even resulted in some controversy regarding the “true” prevalence of autism. ASD are influenced by a variety of genetic, environmental, and possibly immunological factors that act during critical periods to alter key developmental processes. This can affect multiple systems and manifests as the social and behavioral deficits that define these disorders. The interaction of environmental exposures in the context of an individual’s genetic susceptibilities manifests differently in each case, leading to heterogeneous phenotypes and varied comorbid symptoms within the disorder. This has also made it very difficult to elucidate underlying genes and exposure profiles, but progress is being made in this area. Some pharmaceutical drugs, toxicants, and metabolic and nutritional factors have been identified in epidemiological studies as increasing autism risk, especially during the prenatal period. Immunologic risk factors, including maternal infection during pregnancy, autoantibodies to fetal brain proteins, and familial autoimmune disease, have consistently been observed across multiple studies, as have immune abnormalities in individuals with ASD. Mechanistic research using animal models and patient-derived stem cells will help researchers to understand the complex etiology of these neurodevelopmental disorders, which will lead to more effective therapies and preventative strategies. Proposed therapies that need more investigation include special diets, probiotics, immune modulation, oxytocin, and personalized pharmacogenomic targets. The ongoing search for biomarkers and better treatments will result in earlier identification of ASD and provide much needed help and relief for afflicted families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Global Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503 · cited 1×
“In addition, the brain-gut-microbiome connection is increasingly recognized as playing an important role in proper neurodevelopment and also has the ability to modify behavior [62,63].”
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
The Epidemiology of Autism Spectrum Disorders
Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., Mandell, D. S., Miller, L. A., Pinto-Martin, J., Reaven, J., et al. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144007 · Cited by 1,228
FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders
Mariani, J., Coppola, G., Zhang, P., Abyzov, A., Provini, L., Tomasini, L., Amenduni, M., Szekely, A., Palejev, D., Wilson, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.034 · Cited by 1,149
Karst, J. S., & Van Hecke, A. V. (2012) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-012-0119-6 · Cited by 977 · cited 1×
“Those individuals that fall on the more drastically impaired end of the spectrum will require lifelong care, which can have negative psychological consequences for caregivers, usually immediate family members, in addition to creating substantial economic costs and demand for services [11].”
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Atladóttir, H. Ó., Thorsen, P., Østergaard, L., Schendel, D. E., Lemcke, S., Abdallah, M., & Parner, E. T. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1006-y · Cited by 916
Deverman, B. E., & Patterson, P. H. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.002 · Cited by 865
The role of microbiome in central nervous system disorders
Wang, Y., & Kasper, L. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.015 · Cited by 803
Elevated immune response in the brain of autistic patients
Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., & Malik, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.002 · Cited by 786
Boksa, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.03.005 · Cited by 603
The Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders
Kohane, I. S., McMurry, A., Weber, G., MacFadden, D., Rappaport, L., Kunkel, L., Bickel, J., Wattanasin, N., Spence, S., Murphy, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033224 · Cited by 562
The Rise in Autism and the Role of Age at Diagnosis
Hertz-Picciotto, I., & Delwiche, L. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181902d15 · Cited by 522 · cited 1×
“In 2009, another investigation concluded that while several factors, including changes in diagnostic criteria, an earlier age of diagnosis, and the inclusion of milder cases, did contribute to the observed rise in autism, these could not account for the full extent of the increase [8].”
Maternal infection and immune involvement in autism
Patterson, P. H. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.001 · Cited by 520 · cited 1×
“Multiple epidemiological studies provide strong evidence for a connection between maternal infection or the presence of a fever during pregnancy and the development of ASD in the child, for at least a subset of individuals [26].”
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514 · cited 1×
“Agreat numberof independent studies have now implicated a role for the immune system inASDduring both the prenatal and postnatal periods, and many research projects continue to further investigate this link [24,25].”
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Croen, L. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.73 · Cited by 510 · cited 1×
“Maternal treatment with pharmaceutical drugs such as the valproic acid, thalidomide, and antidepressants (specifically selective serotonin reuptake inhibitors), especially during the first trimester of pregnancy, has been associated with an increased risk of ASD in the child [15,16].”
Gupta, S., Ellis, S. E., Ashar, F. N., Moes, A., Bader, J. S., Zhan, J., West, A. B., & Arking, D. E. (2014) · Nature Communications · doi:10.1038/ncomms6748 · Cited by 504
Hansen, S. N., Schendel, D. E., & Parner, E. T. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.1893 · Cited by 461 · cited 1×
“Earlier this year, a population-based study of a large Danish cohort found that 60% of the increase in documented autism prevalence could be attributed to changes in reporting practices, including changes in diagnostic criteria [5].”
Altered gut microbiota and activity in a murine model of autism spectrum disorders
de Theije, C. G. M., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A. D., & Oozeer, R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.005 · Cited by 433
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
Atladóttir, H. O., Pedersen, M. G., Thorsen, P., Mortensen, P. B., Deleuran, B., Eaton, W. W., & Parner, E. T. (2009) · Pediatrics · doi:10.1542/peds.2008-2445 · Cited by 404
Goines, P. E., Croen, L. A., Braunschweig, D., Yoshida, C. K., Grether, J., Hansen, R., Kharrazi, M., Ashwood, P., & Van de Water, J. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-13 · Cited by 351
Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314 · cited 1×
“These chemicals have the additional potential to cause immunotoxicity, which may lead to altered cytokine production frequently observed in ASD [21].”
Altered brain-gut axis in autism: comorbidity or causative mechanisms
Mayer, E. A., Padua, D., & Tillisch, K. (2014) · BioEssays · doi:10.1002/bies.201400075 · Cited by 304
Maternal Infection During Pregnancy and Autism Spectrum Disorders
Zerbo, O., Qian, Y., Yoshida, C., Grether, J. K., Van de Water, J., & Croen, L. A. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-2016-3 · Cited by 298
Differential monocyte responses to TLR ligands in children with autism spectrum disorders
Enstrom, A. M., Onore, C. E., Van de Water, J. A., & Ashwood, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.001 · Cited by 294 · cited 1×
“For instance, monocytes isolated from children with ASD were shown to have differential cytokine responses upon stimulationwith toll-like receptor (TLR) ligands when compared to control children [47].”
Bauman, M. D., Iosif, A.-M., Smith, S. E. P., Bregere, C., Amaral, D. G., & Patterson, P. H. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.025 · Cited by 294
Altered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279
Zerbo, O., Iosif, A.-M., Walker, C., Ozonoff, S., Hansen, R. L., & Hertz-Picciotto, I. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1540-x · Cited by 277
Autism-specific maternal autoantibodies recognize critical proteins in developing brain
Braunschweig, D., Krakowiak, P., Duncanson, P., Boyce, R., Hansen, R. L., Ashwood, P., Hertz-Picciotto, I., Pessah, I. N., & Van de Water, J. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.50 · Cited by 257
Prenatal factors associated with autism spectrum disorder (ASD)
Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.007 · Cited by 238 · cited 3×
“Maternal residential proximity to agricultural applications of pesticides during pregnancy has been associated with an increased risk of ASD, but this scenario may represent abnormally high exposure levels [20].”
Microbiome disturbances and autism spectrum disorders
Rosenfeld, C. S. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063826 · Cited by 229 · cited 1×
“Indeed, alterations in the composition of microbial communities have been detected in ASD, as well as corresponding variations in levels of bacterial metabolites in feces and urine [66].”
Guastella, A. J., & Hickie, I. B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.028 · Cited by 223
Garay, P. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00136 · Cited by 217
Lundstrom, S., Reichenberg, A., Anckarsater, H., Lichtenstein, P., & Gillberg, C. (2015) · BMJ · doi:10.1136/bmj.h1961 · Cited by 212
Immunological and autoimmune considerations of Autism Spectrum Disorders
Gesundheit, B., Rosenzweig, J. P., Naor, D., Lerer, B., Zachor, D. A., Procházka, V., Melamed, M., Kristt, D. A., Steinberg, A., Shulman, C., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.005 · Cited by 207
Chen, S.-W., Zhong, X.-S., Jiang, L.-N., Zheng, X.-Y., Xiong, Y.-Q., Ma, S.-J., Qiu, M., Huo, S.-T., Ge, J., & Chen, Q. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.08.035 · Cited by 194 · cited 1×
“A recently released systematic review and meta-analysis of nine caseecontrol studies and one cohort study from around the world found that maternal autoimmune diseases developed during pregnancy increased the risk of having a child with ASD, again reinforcing that abnormal maternal immune activation can have detriment…”
Peripheral and central inflammation in autism spectrum disorders
Depino, A. M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.003 · Cited by 189
Bauman, M. D., Iosif, A.-M., Ashwood, P., Braunschweig, D., Lee, A., Schumann, C. M., Van de Water, J., & Amaral, D. G. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.47 · Cited by 174
Brimberg, L., Sadiq, A., Gregersen, P. K., & Diamond, B. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.101 · Cited by 172
Parental Autoimmune Diseases Associated With Autism Spectrum Disorders in Offspring
Keil, A., Daniels, J. L., Forssen, U., Hultman, C., Cnattingius, S., Söderberg, K. C., Feychting, M., & Sparen, P. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181f26e3f · Cited by 168
Singer, H. S., Morris, C., Gause, C., Pollard, M., Zimmerman, A. W., & Pletnikov, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.011 · Cited by 164
Kral, T. V. E., Eriksen, W. T., Souders, M. C., & Pinto-Martin, J. A. (2013) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2013.01.008 · Cited by 153
Evidence of the Gluten-Free and Casein-Free Diet in Autism Spectrum Disorders: A Systematic Review
Marí-Bauset, S., Zazpe, I., Mari-Sanchis, A., Llopis-González, A., & Morales-Suárez-Varela, M. (2014) · Journal of Child Neurology · doi:10.1177/0883073814531330 · Cited by 136 · cited 1×
“In particular, a gluten-free and/or casein-free diet might be recommended to combat leaky gut and intestinal inflammation, and although some studies suggest behavioral improvements following the diet, the scientific evidence regarding the effectiveness of this alternative treatment is still very limited [87,88].”
Bresnahan, M., Hornig, M., Schultz, A. F., Gunnes, N., Hirtz, D., Lie, K. K., Magnus, P., Reichborn-Kjennerud, T., Roth, C., Schjølberg, S., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3034 · Cited by 132
Stamou, M., Streifel, K. M., Goines, P. E., & Lein, P. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.12.001 · Cited by 128
Maternal Autoantibodies in Autism
Braunschweig, D., & Van de Water, J. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2506 · Cited by 122
Nevison, C. D. (2014) · Environmental Health · doi:10.1186/1476-069x-13-73 · Cited by 111 · cited 1×
“A slightly older report using data from the US suggests that greater than 70% of the tracked rise in autism since the late 1980s represents a true increase in the disorder rather than a constant-prevalence condition that was underdiagnosed in the past [7].”
Epigenetics of Autism-related Impairment: Copy Number Variation and Maternal Infection
Mazina, V., Gerdts, J., Trinh, S., Ankenman, K., Ward, T., Dennis, M. Y., Girirajan, S., Eichler, E. E., & Bernier, R. (2015) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000126 · Cited by 101
Toward an immune-mediated subtype of autism spectrum disorder
McDougle, C. J., Landino, S. M., Vahabzadeh, A., O’Rourke, J., Zurcher, N. R., Finger, B. C., Palumbo, M. L., Helt, J., Mullett, J. E., Hooker, J. M., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.048 · Cited by 95
Immune Dysregulation in Autism Spectrum Disorder
Hsiao, E. Y. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00009-5 · Cited by 87
Vinet, É., Pineau, C. A., Clarke, A. E., Scott, S., Fombonne, É., Joseph, L., Platt, R. W., & Bernatsky, S. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39320 · Cited by 81
Modeling autism-relevant behavioral phenotypes in rats and mice: Do ‘autistic’ rodents exist?
Servadio, M., Vanderschuren, L. J. M. J., & Trezza, V. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000163 · Cited by 76 · cited 1×
“Animal models are increasingly utilized to investigate the intricate processes and mechanisms underlying ASD behaviors and phenotypes, and they are necessary for any kind of drug or therapeutic testing [71].”
Braunschweig, D., Golub, M. S., Koenig, C. M., Qi, L., Pessah, I. N., Van de Water, J., & Berman, R. F. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.002 · Cited by 71
Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD
Kim, D.-S., Ross, P. J., Zaslavsky, K., & Ellis, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00109 · Cited by 70 · cited 1×
“This is an emerging field that holds great potential, and the optimization and standardization of differentiation protocols will allow for the rapid, efficient generation of desired cell types used for mechanistic studies and drug discovery [86].”
Martínez-Cerdeño, V., Camacho, J., Fox, E., Miller, E., Ariza, J., Kienzle, D., Plank, K., Noctor, S. C., & Van de Water, J. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhu291 · Cited by 63
Heuer, L. S., Rose, M., Ashwood, P., & Van de Water, J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.001 · Cited by 28
Pharmacogenomic Medicine in Autism: Challenges and Opportunities
Bowers, K., Lin, P.-I., & Erickson, C. (2015) · Pediatric Drugs · doi:10.1007/s40272-014-0106-0 · Cited by 22 · cited 1×
“Another emerging, individualized treatment approach is pharmacogenomics, which aims to use personal genetic information to guide pharmacologic interventions that maximize therapeutic benefits while minimizing side-effects [90].”
Cited by
Histone Acetylome-wide Association Study of Autism Spectrum Disorder
Sun, W., Poschmann, J., Cruz-Herrera del Rosario, R., Parikshak, N. N., Hajan, H. S., Kumar, V., Ramasamy, R., Belgard, T. G., Elanggovan, B., Wong, C. C. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.031 · Cited by 306
The role of phthalate esters in autism development: A systematic review
Jeddi, M. Z., Janani, L., Memari, A. H., Akhondzadeh, S., & yunesian, M. (2016) · Environmental Research · doi:10.1016/j.envres.2016.08.021 · Cited by 76
Mahic, M., Mjaaland, S., Bøvelstad, H. M., Gunnes, N., Susser, E., Bresnahan, M., Øyen, A.-S., Levin, B., Che, X., Hirtz, D., et al. (2017) · mSphere · doi:10.1128/msphere.00016-17 · Cited by 56
Frye, R. E., Nankova, B., Bhattacharyya, S., Rose, S., Bennuri, S. C., & MacFabe, D. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01670 · Cited by 51
“In fact two animal models have been developed to parallel prenatal exposure to autoantibodies (61), including fetal brain antibodies (62) and antibodies to the folate transporter (63, 64).”
BackgroundHudac, C. M., Bove, J., Barber, S., Duyzend, M., Wallace, A., Martin, C. L., Ledbetter, D. H., Hanson, E., Goin‐Kochel, R. P., Green‐Snyder, L., et al. (2020) · Autism Research · doi:10.1002/aur.2332 · Cited by 31
Metadata
- Authors
- Matelski, L., & Van de Water, J.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 67
- Pages
- 1-7
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2216023838
- Cited by
- 119
- References
- 63
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.